Triple-Negative Breast Cancer Research and Education Act of 2023

Bill 118 HR 235, also known as the Triple-Negative Breast Cancer Research and Education Act of 2023, is a piece of legislation introduced in the US Congress with the aim of addressing the specific challenges faced by individuals with triple-negative breast cancer. This type of breast cancer is known for being more aggressive and harder to treat than other forms of the disease.

The bill proposes to allocate funding for research into triple-negative breast cancer, with the goal of developing more effective treatments and improving outcomes for patients. Additionally, the legislation seeks to increase public awareness and education about this type of breast cancer, in order to promote early detection and improve access to care for those affected.

If passed, the Triple-Negative Breast Cancer Research and Education Act of 2023 would represent a significant step forward in the fight against this deadly disease, providing much-needed support for patients, caregivers, and healthcare providers. It is a bipartisan effort to prioritize research and education in the fight against triple-negative breast cancer.